Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» China
China
Bristol Myers Squibb is nixing BeiGene's Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame?
Fierce Pharma
Thu, 10/14/21 - 11:09 am
cancer
Bristol Myers Squibbe
BeiGene
Abraxane
China
drug manufacturing
A newly private Novartis partner bags a megaround on its first go to turbocharge CAR-T, cell therapy pipeline
Endpoints
Thu, 09/30/21 - 11:04 am
Novartis
China
Cellular Biomedicine
Hua Medicine May be Sending Type 2 Diabetes into Remission
BioSpace
Tue, 09/28/21 - 12:01 am
Hua Medicine
China
diabetes
type 2 diabetes
Sandoz in oncology biosimilar deal with China’s Bio-Thera
Biopharma Reporter
Wed, 09/8/21 - 11:15 am
Sandoz
Novartis
biosimilars
China
BAT1706
Bio-Thera Solutions
Backed by Eli Lilly, a little-known and secretive Chinese biotech fills the tank as it heads to the clinic
Endpoints
Fri, 08/27/21 - 10:57 am
China
Eli Lilly
Lilly Asia Ventures
Lynk Pharmaceuticals
China's mRNA vaccine technology firm Abogen raises over $700 mln
Reuters
Thu, 08/19/21 - 11:09 am
Abogen
MRNA
vaccines
China
funding
SeaGen builds cancer drug pipeline with China biotech deal
BioPharma Dive
Mon, 08/9/21 - 11:47 pm
Seagen
China
breast cancer
bladder cancer
stomach cancer
RemeGen
Oyster Point Pharma Inks Deal with Ji Xing for Dry Eye Disease Therapies
BioSpace
Sun, 08/8/21 - 12:00 am
Oyster Point Pharma
Ji Xing Pharmaceuticals
OC-01
OC-02
dry eye disease
China
AstraZeneca earns another approval in jam-packed Chinese PD-(L)1 market, this time in late-stage lung cancer
Endpoints
Mon, 07/19/21 - 11:05 am
AstraZeneca
China
Imfinzi
A Chinese I/O biotech looking to turn around an old Novartis program gets a new fundraise after launching PhIII study
Endpoints
Thu, 07/15/21 - 10:46 am
China
immuno-oncology Adlai Nortye
Novartis
funding
Biogen builds MS pipeline via $125m deal with China’s InnoCare
Pharmaforum
Tue, 07/13/21 - 10:39 am
Biogen
MS
multiple sclerosis
China
InnoCare
BeiGene dives in on natural killer cells with discovery pact for small biotech's stem cell-based platform
Endpoints
Wed, 06/9/21 - 11:09 am
BeiGene
China
natural killer cells
cell therapy
Shoreline Biosciences
FDA review of Lilly/Innovent’s sintilimab paves way for cut-price immunotherapy option
Pharmaforum
Wed, 05/19/21 - 10:26 am
Eli Lilly
Innovent
China
sintilimab
Keytruda
Merck
immunotherapy
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Fierce Biotech
Mon, 05/17/21 - 10:44 am
LianBio
Landos Biopharma
IPOs
ulcerative colitis
Crohn's Disease
China
Asia
U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech
Yahoo/Reuters
Sun, 05/9/21 - 11:01 pm
Joe Biden
COVID-19
vaccines
patents
China
Russia
intellectual property
Sanofi reports sales growth amid Dupixent's China launch, but reveals PDUFA delay in Pompe disease program
Endpoints
Wed, 04/28/21 - 10:30 am
Sanofi
earnings
China
Dupixent
Pompe disease
Nearing a COVID-19 vaccine approval in China, Fosun gears up to launch BioNTech shot: report
Fierce Pharma
Thu, 04/22/21 - 11:35 pm
China
Fosun Pharmaceutical
vaccines
BioNTech
COVID-19
Chime Bio, flush with $190M, blueprints major biomanufacturing boost in China
Fierce Pharma
Tue, 04/6/21 - 10:30 am
Chime Bio
CDMO
drug manufacturing
China
Pfizer halts biosimilar programs in crowded China market, sells plant to WuXi Biologics
Fierce Pharma
Wed, 03/17/21 - 11:39 pm
Pfizer
China
biosimilars
WuXi Biologics
Bristol Myers offloading Swiss tablet and capsule plant to Chinese CDMO WuXi STA
Fierce Pharma
Tue, 02/2/21 - 11:15 pm
Bristol-Myers Squibb
CDMO
China
WuXi Biologics
ISTA Pharmaceuticals
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »